SCHEMBL1876507

SCHEMBL1876507

O=CCc1ccc2c(F)cc(F)cc2c1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.48
▸ ERN1 O75460 1/20 0.32
▸ PTGER3 P43115 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11737047 0.80 AKR1B1 (0.34) CYP19A1ERN1
SCHEMBL11739271 0.79 CYP1A2 (0.46) CYP19A1
SCHEMBL11743633 0.77 CYP19A1 (0.45) CYP19A1
SCHEMBL14604946 0.77 CYP19A1 (0.50) CYP19A1
SCHEMBL1872412 0.76 TAAR1 (0.52) CYP19A1
SCHEMBL896163 0.71 HTT (0.42) —
SCHEMBL29387575 0.71 KDM1A (0.35) —
SCHEMBL1426991 0.71 KDM1A (0.35) —
SCHEMBL11746558 0.69 CYP1A2 (0.46) ERN1
SCHEMBL11742103 0.69 TDP1 (0.33) ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2533778-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE Lexicon Pharmaceuticals, Inc. (US) 2012-12-19 — — EP disclosed
EP-2496231-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER Lexicon Pharmaceuticals, Inc. (US) 2012-09-12 — — EP disclosed
WO-2011100285-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE LEXICON PHARMACEUTICALS, INC. (US) 2011-08-18 — — WO disclosed
WO-2011056916-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF CANCER LEXICON PHARMACEUTICALS, INC. (US) 2011-05-12 — — WO disclosed
Send feedback